ArticleFrontiers in oncology2022

Chenodeoxycholic Acid Enhances the Effect of Sorafenib in Inhibiting HepG2 Cell Growth Through EGFR/Stat3 Pathway.

Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.